Home › Phico Therapeutics gets A 2.25M Translation Award to develop SASPject ...
 

Keywords :   


Phico Therapeutics gets A 2.25M Translation Award to develop SASPject ...

2015-03-09 12:33:20| Biotech - Topix.net

Phico Therapeutics, a biotechnology company developing a novel platform technology for a new generation of antibiotics aimed at overcoming antibacterial resistance, has been awarded a 2.25M Translation Award by the Wellcome Trust to develop its SASPject PT4 antibiotic, aimed at Escherichia coli and Klebsiella pneumonia e . SASPject 's PT4 is targeted at E. coli and K. pneumoniae , including multi-drug resistant strains.

Tags: develop award translation therapeutics

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
04.05Weekly Recap: Sherwin-Williams, BASF, Abrafati Top This Weeks Stories
03.05'Garden floods show need to work with nature'
03.05Worst-ever job interviews: 'We had to crawl and moo'
03.05Have the wheels come off for Tesla?
03.05BW Converting focuses on time, energy and cost savings at INFOFLEX
03.05Navigator Paper Ups Offer for Accrual
03.05USDA urged to restore NASS surveys
03.05Dilo Hosts Open House
More »